Trinity Biotech (TRIB) Other Working Capital Changes (2021 - 2024)

Trinity Biotech has disclosed Other Working Capital Changes across 4 years of filings, most recently posting $7.0 million for Q4 2024.

• In Q4 2024, Other Working Capital Changes rose 169.41% year-over-year to $7.0 million; the TTM figure through Dec 2024 stood at $6.9 million (up 168.56% YoY), while the FY2025 annual figure was -$908000.0, down 136.25% from the prior year.
• Other Working Capital Changes came in at $7.0 million for Q4 2024 at Trinity Biotech, up from $57000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $10.2 million in Q4 2020 to a low of -$3.2 million in Q2 2021.
• Average Other Working Capital Changes over 5 years is -$509055.6, with a median of -$1.4 million recorded in 2018.
• The largest YoY upside for Other Working Capital Changes was 169.41% in 2024 against a maximum downside of 178.46% in 2024.
• Over 4 years, Other Working Capital Changes stood at $4.9 million in 2021, then tumbled by 37.57% to $3.1 million in 2022, then decreased by 15.0% to $2.6 million in 2023, then jumped by 169.41% to $7.0 million in 2024.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $7.0 million in Q4 2024, $57000.0 in Q3 2024, and -$55000.0 in Q2 2024.